Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-24

Clinical Trial Update: Efficacy of Mazdutide for Treating PCOS [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the efficacy of Mazdutide for treating Polycystic Ovary Syndrome, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mazdutide (Mazdutide)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Polycystic Ovary Syndrome | Phase 1, Phase 2 | Status: RECRUITING